Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Variants of TACE pro-domain as TNF-A inhibitor and their medical use

Variants of TACE pro-domain as TNF-A inhibitor and their medical use

US Patent 10933122 · Granted Mar 2, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions for remodeling extracellular matrix and methods of use thereof2025
Anti-matrix metalloproteinase 7 (MMP-7) inhibitory antibody and uses thereof2025
Anti third party central memory t cells, methods of producing same and use of sa2024
Compositions for remodeling extracellular matrix and methods of use thereof2023
Methods of preventing secondary infections2022
Compositions for remodeling extracellular matrix and methods of use thereof2022
Anti third party central memory T cells, methods of producing same and use of sa2022
Compositions for remodeling extracellular matrix and methods of use thereof2020
Methods of preventing secondary infections2020
Variants of TACE pro-domain as TNF-A inhibitor and their medical use2019
Variants of TACE pro-domain as TNF-A inhibitor and their medical use2019
Variants of TACE pro-domain as TNF-A inhibitor and their medical use2019